International Journal of Cardiology
Volume 107, Issue 3 , Pages 395-399 , 8 March 2006

Impact of body mass index on short-term outcome after acute myocardial infarction: Does excess body weight have a paradoxical protective role?

Received 6 December 2004 ,Revised 31 March 2005 ,Accepted 1 April 2005.

References 

  1. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the nutrition committee, American Heart Association. Circ. 1997;96:3248–3250
  2. Rao SV, Donahue M, Pi-Sunyer X, et al. Obesity as a risk factor in coronary artery disease. Am Heart J. 2001;142:1102–1107
  3. Suwaidi JA, Higano ST, Holmes DR, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 2001;37:1523–1538
  4. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary artery disease. Circ. 1998;97:2099–2100
  5. Hoit BD, Gilpin EA, Maisel AA, et al. Influence of obesity on morbidity and mortality after acute myocardial infarction. Am Heart J. 1987;114:1334
  6. Gurm HS, Brennan DM, Booth J, Tcheng JE, Lincoff M, Topol EJ. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol. 2002;90:42–45
  7. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow E, et al. The impact of obesity on the short-term and long term outcomes after percutaneous coronary intervention: the obesity paradox?. J Am Coll Cardiol. 2002;39:578–584
  8. Gurm HS, Whitlow PL, Kip KE. The impact of body mass index on short- and long-term outcomes in patients undergoing coronary revascularization. Insights from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 2002;39:834–840
  9. Schunkert H, Harrel L, Palacios IF. Implication of small reference vessel diameter in patients undergoing percutaneous revascularization. J Am Coll Cardiol. 1999;34:40–48
  10. Lundergan CF, Ross AM, McCarthy WF, Reiner JS, Boyle D, Fink C, et al. Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency and body mass index. The GUSTO-I angiographic experience. Am Heart J. 2001;142:43–50
  11. Anker S, Ponikowski P, Varney S, Chua TP, Clark AL, Webb Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–1053
  12. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WB, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789–795
  13. Dell DD. Cachexia in patients with advanced cancer. Clin J Oncol Nurs. 2002;6:235–238
  14. Mulligan K, Schambelan M. Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. Int J Cardiol. 2002;85:151–159
  15. Muers MF, Green JH. Weight loss in chronic obstructive pulmonary disease. Eur Respir J. 1993;6:729–734
  16. Anker SD, Negassa A, Coats AJS, Afzal R, Poole-Wilson PA, Cohn JN. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361:1077–1083
  17. Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in Chronic Systolic heart failure: the obesity paradox. Am J Card Imaging. 2003;91:891–894
  18. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJS, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9:29–35
  19. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circ. 1997;96:526–534
  20. Weber MA, Neutel JM, Smith DHG. Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J Am Coll Cardiol. 2001;37:169–174
  21. Feldman AM, Combes A, Wagner D, et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 2000;35:537–544
  22. Bray GA. Classification and evaluation of the obesities. Med Clin North Am. 1989;32:641–647

PII: S0167-5273(05)00628-5

doi: 10.1016/j.ijcard.2005.04.005

International Journal of Cardiology
Volume 107, Issue 3 , Pages 395-399 , 8 March 2006

Article Tools

* Image Usage & Resolution